Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report.

Saved in:
Bibliographic Details
Title: Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report.
Authors: Bartley CM; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States., Ngo TT; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, United States., Cadwell CR; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.; Department of Pathology, University of California, San Francisco, San Francisco, CA, United States., Harroud A; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Schubert RD; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Alvarenga BD; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Hawes IA; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.; Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, United States., Zorn KC; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, United States., Hunyh T; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Teliska LH; Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States., Kung AF; School of Medicine, University of California, San Francisco, San Francisco, CA, United States., Shah S; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, United States.; Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, United States., Gelfand JM; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Chow FC; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Rasband MN; Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States., Dubey D; Department of Neurology, Mayo Clinic Foundation, Rochester, MN, United States.; Department of Laboratory Medicine and Pathology, Mayo Clinic Foundation, Rochester, MN, United States., Pittock SJ; Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, United States.; Department of Neurology, Mayo Clinic Foundation, Rochester, MN, United States.; Department of Laboratory Medicine and Pathology, Mayo Clinic Foundation, Rochester, MN, United States., DeRisi JL; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, United States.; Chan Zuckerberg Biohub, San Francisco, CA, United States., Wilson MR; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States., Pleasure SJ; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.; Department of Neurology, University of California, San Francisco, San Francisco, CA, United States.
Source: Frontiers in neurology [Front Neurol] 2023 Jan 23; Vol. 13, pp. 1102484. Date of Electronic Publication: 2023 Jan 23 (Print Publication: 2022).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-2295
DOI:10.3389/fneur.2022.1102484